Cas:568572-19-0 2-(4-Methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane manufacturer & supplier

Chemical Name:2-(4-Methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

CAS.NO:568572-19-0

Synonyms:1,3,2-Dioxaborolane, 2-(4-methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-;2-(4-Methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Molecular Formula:C₁₅H₂₃BO₃

Molecular Weight:262.152

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:356.5±42.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.491

PSA:

Exact Mass:262.174011

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,3,2-Dioxaborolane, 2-(4-methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(4-Methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1,3,2-Dioxaborolane, 2-(4-methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl- Use and application,1,3,2-Dioxaborolane, 2-(4-methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl- technical grade,usp/ep/jp grade.

Related News: A U.S. Senator, New Jersey Democrat Bob Menendez, called allegations of manufacturing irregularities and records tampering at the Branchburg plant troubling. Menendez has sponsored a bill calling for a non-partisan, independent COVID-19 Commission to examine the U.S. pandemic response, including government contracts with companies. 2-(4-Methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane manufacturer The drug, Imfinzi, when added to chemotherapy and the drugmaker��s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said. 2-(4-Methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane supplier At the same time, because the profits of a single variety of characteristic APIs do not have long-term growth, companies need more product reserves. 2-(4-Methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane vendor CROS NT built up its own biometric services portfolio: clinical data management, biostatistics, statistical programming and medical writing, through a series of acquisitions in the early 2010s. In 2013, CROS NT established a foothold in the U.S. with its purchase of Stat-Tech Services, which had a presence in the medical devices sector. CROS NT followed up the next year with its buy of biometrics services provider MDSL International to broaden its U.K. branch. 2-(4-Methoxy-3,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane factory CROS NT built up its own biometric services portfolio: clinical data management, biostatistics, statistical programming and medical writing, through a series of acquisitions in the early 2010s. In 2013, CROS NT established a foothold in the U.S. with its purchase of Stat-Tech Services, which had a presence in the medical devices sector. CROS NT followed up the next year with its buy of biometrics services provider MDSL International to broaden its U.K. branch.